Candis Lovelace, MD
Plastic and Reconstructive Surgery · Fort Worth, TXNPI 1811037245
Payments from drug & device makers
Across 76 payments — averaging $105.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Stryker$2K
- Sientra, Inc.$2K
- Amgen$141
- Integra Lifesciences Corporation$133
- AstraZeneca$125
- plus $1K from 23 others
What the payments were for
- Travel & lodging$4,55457%
- Food & beverage$3,45943%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 15 | $2,776 |
| Stryker | 4 | $1,882 |
| Sientra, Inc. | 12 | $1,514 |
| Amgen | 1 | $141 |
| Integra Lifesciences Corporation | 4 | $133 |
| AstraZeneca | 1 | $125 |
| Paratek Pharmaceuticals, Inc. | 2 | $124 |
| Revance Therapeutics, Inc. | 3 | $107 |
| Idorsia Pharmaceuticals US Inc | 2 | $103 |
| Teva Pharmaceuticals USA, Inc. | 1 | $101 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $100 |
| Lilly USA, LLC | 1 | $99 |
| Amarin Pharma, Inc. | 1 | $97 |
| Merck | 1 | $85 |
| Mentor Worldwide LLC | 5 | $83 |
| Medtronic | 1 | $80 |
| Motiva USA, LLC | 1 | $75 |
| Tepha Inc | 1 | $69 |
| Avita Medical Americas, LLC | 2 | $67 |
| TELA Bio, Inc. | 6 | $66 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $28 |
| Pylant Medical | 1 | $24 |
| Davol Inc. | 1 | $24 |
| Galderma Laboratories, L.p. | 1 | $23 |
| Acelrx Pharmaceuticals, Inc. | 1 | $22 |
| Mimedx Group, Inc. | 1 | $18 |
| Smith+Nephew | 1 | $15 |
| Apyx Medical Corporation | 1 | $15 |
| Baudax Bio Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE SALINE-FILLED BREAST IMPLANTS$4,028
- REVOLVE$2,014
- 1588 HD 3 CHIP CAMERA$1,298
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$1,155
- SPY-PHI SYSTEM$489
- EVENITY$141
- UBRELVY$126
- FARXIGA$125
- NATRELLE$119
- VRAYLAR$107
- NUZYRA$105
- AUSTEDO$101
How this compares
$8,013 in reported general payments places this provider in the 70th percentile of 378 plastic and reconstructive surgery providers in Texas.
See all plastic and reconstructive surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 60 | $312 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $179 |
| Mupirocin | 19 | $156 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Fort Worth
- Steven MapulaFort Worth$234K
- Robert AndersonFort Worth$75K
- Srikanth KurapatiFort Worth$44K
- Aldona SpiegelHouston$884K
- Patrick GarveyHouston$411K
- Charles ButlerHouston$227K
- Joshua LemmonRichardson$212K
- Michael KlebucHouston$204K
- Jeffrey FriedmanHouston$159K
- Patrick ProfferAmarillo$151K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.